We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+10.24%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$84.1B
AUM Growth
+$6.96B
(+9%)
Cap. Flow
+$592M
Cap. Flow
% of AUM
0.7%
Top 10 Holdings %
Top 10 Hldgs %
8.18%
Holding
2,626
New
166
Increased
1,055
Reduced
1,187
Closed
213
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$248M |
| 2 |
Cognizant
CTSH
|
+$201M |
| 3 |
Principal Financial Group
PFG
|
+$193M |
| 4 |
Raymond James Financial
RJF
|
+$186M |
| 5 |
Expeditors International
EXPD
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Parker-Hannifin
PH
|
+$194M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$187M |
| 3 |
Illinois Tool Works
ITW
|
+$183M |
| 4 |
Cincinnati Financial
CINF
|
+$181M |
| 5 |
Humana
HUM
|
+$178M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.97% |
| 2 | Financials | 12.62% |
| 3 | Healthcare | 12.06% |
| 4 | Industrials | 10.19% |
| 5 | Energy | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Glaukos
GKOS
$8.92B
| $1.85M | ﹤0.01% |
42,320
-2,735
| -6% | -$135K |
|
|
CDMO
1727
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.85M | ﹤0.01% |
+134,196
| New | +$2.06M |
|
1728
TRI-Continental Corp
TY
$1.86B
| $1.84M | ﹤0.01% |
71,847
-382
| -0.5% | -$10.2K |
|
1729
Lloyds Banking Group
LYG
$89B
| $1.82M | ﹤0.01% |
825,583
-151,562
| -16% | -$312K |
|
1730
Amphastar Pharmaceuticals
AMPH
$846M
| $1.82M | ﹤0.01% |
+64,989
| New | +$1.89M |
|
|
FFIC
1731
DELISTED
Flushing Financial
FFIC
| $1.82M | ﹤0.01% |
93,959
+7,653
| +9% | +$154K |
|
1732
Mativ Holdings
MATV
$455M
| $1.82M | ﹤0.01% |
+87,022
| New | +$1.89M |
|
1733
Southwest Gas
SWX
$6.66B
| $1.81M | ﹤0.01% |
29,326
+1,649
| +6% | +$112K |
|
1734
Grid Dynamics Holdings
GDYN
$514M
| $1.81M | ﹤0.01% |
161,589
-21,377
| -12% | -$277K |
|
1735
Vanguard FTSE Europe ETF
VGK
$30.1B
| $1.81M | ﹤0.01% |
32,694
-12,126
| -27% | -$640K |
|
|
SOVO
1736
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $1.81M | ﹤0.01% |
+125,871
| New | +$1.76M |
|
1737
Shutterstock
SSTK
$216M
| $1.8M | ﹤0.01% |
34,209
+8,365
| +32% | +$426K |
|
1738
iShares MSCI USA Quality Factor ETF
QUAL
$46B
| $1.8M | ﹤0.01% |
15,783
+377
| +2% | +$42.8K |
|
|
VRE
1739
DELISTED
Veris Residential
VRE
| $1.79M | ﹤0.01% |
112,273
+19,458
| +21% | +$287K |
|
1740
John B. Sanfilippo & Son
JBSS
$978M
| $1.79M | ﹤0.01% |
21,959
-1,526
| -6% | -$124K |
|
|
CFB
1741
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $1.78M | ﹤0.01% |
143,699
+12,128
| +9% | +$161K |
|
1742
Enact Holdings
ACT
$6.57B
| $1.78M | ﹤0.01% |
73,905
+2,151
| +3% | +$52.5K |
|
1743
Usana Health Sciences
USNA
$412M
| $1.78M | ﹤0.01% |
33,390
+5,373
| +19% | +$291K |
|
1744
MACOM Technology Solutions
MTSI
$20.1B
| $1.77M | ﹤0.01% |
+28,122
| New | +$1.76M |
|
1745
Li Auto
LI
$13.1B
| $1.77M | ﹤0.01% |
86,713
-357,973
| -81% | -$6.81M |
|
1746
BlackRock Science and Technology Trust
BST
$1.58B
| $1.77M | ﹤0.01% |
62,315
-1,817
| -3% | -$55.4K |
|
1747
Dorman Products
DORM
$4.08B
| $1.77M | ﹤0.01% |
21,827
-13,167
| -38% | -$1.12M |
|
1748
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.8B
| $1.76M | ﹤0.01% |
11,441
+1,243
| +12% | +$183K |
|
1749
Park National Corp
PRK
$3.43B
| $1.76M | ﹤0.01% |
12,503
-7,328
| -37% | -$1.03M |
|
|
KRTX
1750
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.75M | ﹤0.01% |
8,914
-3,991
| -31% | -$856K |
|
Similar funds
DAM
First Trust Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, First Trust Advisors held 2,626 positions worth $84.1B, up 9% from $77.1B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
First Trust Advisors's Q4 2022 filing shows 166 new, 1,055 increased, 1,187 reduced and 213 closed positions. Its largest new stake was First Trust Limited Duration Investment Grade Corporate ETF: 3,152,528 shares worth $58.9M. The largest sale was Parker-Hannifin, an estimated $194M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- First Trust Advisors's largest Q4 2022 buy was First Trust Limited Duration Investment Grade Corporate ETF: 3,152,528 shares worth $58.9M.
- First Trust Advisors added most to Accenture in Q4 2022, an estimated $248M increase.
- First Trust Advisors's biggest Q4 2022 reduction was Parker-Hannifin, cutting an estimated $194M.
- First Trust Advisors fully exited First Trust Global Tactical Commodity Strategy Fund in Q4 2022, selling an estimated $144M.
- First Trust Advisors's ten largest holdings make up 8.2% of its $84.1B portfolio in Q4 2022.
- First Trust Advisors opened 166 new positions and closed 213 in Q4 2022.
- First Trust Advisors's portfolio value rose 9% quarter-over-quarter to $84.1B.
Based on First Trust Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.